Regulation 1
Citation and commencement
This Order is the Interpretation (Health Sciences Authority Act — Fees) Order 2017 and comes into operation on 11 October 2017.
/akn/sg/act/sub_leg/1965/IA-S577-2017
The full official text, structured for quick navigation. Copy any provision or jump straight to a section.
Quick answer
Interpretation (Health Sciences Authority Act — Fees) Order 2017 is Singapore Subsidiary Legislation, cited as Subsidiary Legislation IA-S577-2017 1965, currently marked in force and first recorded in 1965.
Citation and commencement
This Order is the Interpretation (Health Sciences Authority Act — Fees) Order 2017 and comes into operation on 11 October 2017.
Definitions
In this Order —“Authority” means the Health Sciences Authority established under section 3 of the Health Sciences Authority Act 2001;“cell, tissue or gene therapy product” means a health product categorised as a cell, tissue or gene therapy product in the First Schedule to the Health Products Act 2007;“medical device” means a health product categorised as a medical device in the First Schedule to the Health Products Act 2007.
“Authority” means the Health Sciences Authority established under section 3 of the Health Sciences Authority Act 2001;
“cell, tissue or gene therapy product” means a health product categorised as a cell, tissue or gene therapy product in the First Schedule to the Health Products Act 2007;
“medical device” means a health product categorised as a medical device in the First Schedule to the Health Products Act 2007.
Fees for consultancy services
The fees specified in the second column of the Schedule are payable to the Authority for the consultancy services under section 12(d) of the Health Sciences Authority Act 2001 specified opposite in the first column.